PIK3CA and glioblastoma: Either the activating mutations of PIK3CA or inactivating mutations of PTEN in the phosphoinositide 3-kinase (PI3K) pathway could present as co-mutations with EGFRvIII of MAPK pathway in glioblastoma in this cohort study.